We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enzyme Expression Regulates Immune Response

By Biotechdaily staff writers
Posted on 10 Sep 2003
Researchers working with a mouse model have found that expression of the enzyme indoleamine 2,3 dioxygenase (IDO) on the surface of immune dendritic cells determines whether they activate or suppress T-cell response.

Capitalizing on recent findings that the drug CTLA4-Ig, a reagent designed to block the action of T-cells, induced IDO in dendritic cells, investigators at the Medical College of Georgia (Augusta, USA) treated normal and IDO knock-out mice with the drug. More...
They found that CTLA4-Ig did not induce IDO expression in macrophages or lymphoid cells. On the other hand, induction of IDO completely blocked clonal expansion of T-cells from transgenic mice following adoptive transfer, whereas CTLA4-Ig treatment did not block T-cell clonal expansion in IDO-deficient recipients. These findings were published in the August 15, 2003, issue of the Journal of Immunology.

"One of the things we argue in this paper is that we can use IDO to help us find out if dendritic cells are going to stimulate the immune system or turn it off. If they express IDO, they will not stimulate T-cells to respond. If they do not express IDO, they are likely to stimulate immune responses once they mature,” explained senior author Dr. Andrew L. Mellor, director of the Immunotherapy Center at the Medical College of Georgia. "It comes back to the unifying theme of what it is at the molecular and cellular level that regulates whether the immune system is going to respond or not to any given circumstance.”



Related Links:
Medical College of Georgia

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automatic CLIA Analyzer
Shine i6000
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.